LumiraDx
Hospitals and Health Care
London, London 19,275 followers
Transforming community-based healthcare through POC diagnostics & making lab-comparable tests accessible to all
About us
LumiraDx is a next-generation point of care diagnostics company that is transforming community-based healthcare. Founded in 2014, the company manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. LumiraDx diagnostic testing solutions are being deployed by governments and leading healthcare institutions across laboratories, urgent care, physician offices, pharmacy, schools, and workplaces to screen, diagnose and monitor wellness as well as disease. The company has on the market and in development 30+ tests covering infectious diseases, cardiovascular disease, diabetes and coagulation disorders, all on the LumiraDx Platform. In addition, the company has a comprehensive portfolio of fast, accurate and cost-efficient COVID-19 testing solutions from the lab to point of need.
- Website
-
http://www.lumiradx.com
External link for LumiraDx
- Industry
- Hospitals and Health Care
- Company size
- 501-1,000 employees
- Headquarters
- London, London
- Type
- Public Company
- Founded
- 2014
- Specialties
- HIE, Patient Engagement, PHR, Accountable Care, Care Management, Wellness, Health Coaching, Health Information Exchange, Care Coordination, Clinical Integration, Population Health Management, Interoperability, EHR, Diagnostics, Activity Tracking, mHealth, and Point of Care
Locations
-
Primary
Get directions
3 More London Riverside
London, London SE1 2AQ, GB
-
Get directions
221 Crescent St
Waltham, Massachusetts 02453, US
Employees at LumiraDx
Updates
-
This week is #AMR awareness week. Antimicrobial resistance (AMR) is one of the greatest threats to global health, food security and development, and the misuse of antibiotics is accelerating antimicrobial resistance globally. #CRP testing in primary care can help optimise prescribing by delivering rapid, quantitative results in just 4 minutes. Find out more: https://okt.to/huMPCp * Cooke J. et al. RTIs in primary care: narrative review of CRP POCT.BMJ.2020;7e000624. doi:10.1136/bmjresp-2020-000624
-
-
Today is #WorldDiabetesDay Globally, 537 million people are living with diabetes and nearly half of all diabetes cases are undiagnosed.* Point of care testing can help improve access to diagnostic solutions, providing better outcomes and better health for those living with diabetes. #DiabetesLife #HbA1c *https://lnkd.in/eWKEPt5e
-
Today Kym Wallace and April R. from our UK team are in Glasgow for the POCT-for-Scot Ltd Ltd 'Bringing the future to you' conference. If you're attending, you can meet Kym and April on our exhibition stand where you can have a demonstration of our #pointofcare LumiraDx Platform and find out more about our range of lab-comparable tests with results in minutes.
-
-
The LumiraDx Platform is powered by actively controlled microfluidics. Our technology condenses the concepts of a large laboratory analyzer into a small, portable instrument to deliver lab-comparable performance in minutes. Here's how it works: https://okt.to/SNHZwg
-
-
Mobile teams across the world are taking diagnostic testing right to the point of need. The LumiraDx Platform is fully portable and battery operated - perfect for testing in the community. #POC Click here to find out more: https://okt.to/iV7FSE
-
-
One Platform, multiple tests. Learn more about LumiraDx providing fast, high performance and accessible diagnostic solutions at the point of need with our range of lab-comparable tests. #POC #Diagnostics
-
-
We are delighted to announce the completion of the acquisition of LumiraDx’s Point of Care technology by Roche today. This represents a great step on the road of transforming community based healthcare with our next generation platform. https://lnkd.in/eCeTN9Zq
We are pleased to announce today the completion of the acquisition of LumiraDx’s Point of Care technology, enabling us to further accelerate innovation in near-patient care. It will also help to expand patient access to timely diagnostics results in community-based care, especially in low and middle-income countries.
-
More power to emergency care The LumiraDx Platform and range of assays are being used in hospitals across the globe to help triage patients and make treatment decisions quickly. Click here to see how South Champagne hospital are embracing point of care technology to help improve efficiencies in emergency care: https://okt.to/Oid9Jx
-
-
Virtual wards, also known as Hospital@Home services, allow patients to get the care they need at home rather than being in hospital. ✔ Supporting patients who would otherwise need hospitalisation ✔ Reducing the length of hospital stay ✔ Helping people live well at home for longer with more input into the care and support they receive The LumiraDx Platform is fully portable, battery-operated and simple to use which makes it ideal for community and mobile testing. With lab-comparable performance, and small sample volumes, our tests are able to support real-time decision making in the patient's home. To learn more about how Frimley Health NHS Foundation Trust have incorporated point of care testing into their rapid community response service click here - https://okt.to/iks4la #virtualwards #POC
-